Testosterone Enanthate Adolescent (12 to 17) Caregiver Administration Guidance

What Is Testosterone Enanthate and Why Is It Prescribed to Adolescents?

Testosterone enanthate is a long-acting ester of testosterone dissolved in sesame oil for intramuscular injection. In adolescents aged 12 to 17, it is most commonly prescribed for male hypogonadism and constitutional delay of growth and puberty (CDGP), two conditions where endogenous testosterone production is insufficient to drive normal pubertal development. The drug's half-life of approximately 4.5 days allows bi-weekly or monthly dosing schedules that fit a family's routine. [1]

Approved Indications in Adolescent Males

The FDA-approved labeling for testosterone enanthate covers male hypogonadism resulting from testicular failure, hypothalamic or pituitary dysfunction, or surgery or radiation damage to those structures. [2] Constitutional delay of growth and puberty, while sometimes managed off-label, is consistently addressed in Endocrine Society guidance as an appropriate short-course indication using low-dose testosterone esters. [3]

How the Drug Works

Testosterone binds androgen receptors in muscle, bone, brain, and secondary sex organs. In a pubertal-age male with low endogenous testosterone, exogenous testosterone enanthate replaces the signal needed to advance Tanner staging, drive linear growth, and support bone mineral accrual. A 2019 study in the Journal of Clinical Endocrinology and Metabolism (JCEM) confirmed that short-course low-dose testosterone therapy in CDGP males produced a mean testicular volume increase of 2.3 mL at 6 months compared with 0.6 mL in untreated controls. [4]

Who Should NOT Use This Drug

Testosterone enanthate is contraindicated in adolescents with known or suspected androgen-sensitive tumors, serious cardiovascular disease, or hypercalcemia associated with malignancy. Female adolescents must not receive this formulation for gender-affirming therapy without specific physician oversight and a confirmed informed-consent process, as virilizing effects are irreversible. [2]

Caregiver Training Before the First Injection

No caregiver should administer testosterone enanthate at home without completing a structured training session with a licensed nurse or the prescribing physician. Training is not optional. A single poorly executed injection risks abscess formation, nerve injury, or inadvertent intravenous delivery.

What the Training Session Should Cover

A training session typically runs 30 to 45 minutes and includes:

• Anatomy of safe injection sites (vastus lateralis and ventrogluteal regions)
• Aseptic technique, including hand hygiene and vial cleaning
• Drawing up an oily solution correctly (testosterone enanthate in sesame oil is viscous and requires a larger-bore draw needle, typically 18 to 21 gauge, then swapped to an injection needle of 22 to 25 gauge, 1 to 1.5 inches)
• Needle disposal in a puncture-resistant sharps container
• Recognition of injection-site reactions

The Endocrine Society's 2023 clinical practice guideline on male hypogonadism states: "Patients and caregivers should receive detailed instruction in self-injection or caregiver-injection technique from qualified clinical personnel before initiating home therapy." [3]

Documentation the Caregiver Should Bring Home

After training, request a written instruction sheet from the clinic that includes the exact dose in milligrams (not just volume), the vial concentration (testosterone enanthate is commercially available as 200 mg/mL in the United States), the injection site rotation schedule, and the clinic's after-hours contact number. Keeping this sheet with the medication eliminates dosing guesswork.

Step-by-Step Injection Procedure

Precision matters at every step. A caregiver who follows these steps consistently reduces the risk of site reactions and ensures the full dose reaches the muscle.

Supplies Needed for Each Injection

| Item | Specification | |---|---| | Testosterone enanthate vial | Per prescription; typically 200 mg/mL | | Draw needle | 18 to 21 gauge, 1.5-inch | | Injection needle | 22 to 25 gauge, 1 to 1.5-inch | | Alcohol swabs | 70% isopropyl alcohol | | Sterile gauze | 2x2 inch | | Sharps container | FDA-cleared, puncture-resistant | | Non-latex gloves | Optional but recommended |

Preparing the Dose

1. Wash hands thoroughly with soap and water for at least 20 seconds.
2. Inspect the vial visually. Testosterone enanthate in sesame oil is a pale-yellow to amber oily solution. Discard if you see particles, cloudiness, or discoloration.
3. Wipe the rubber stopper with an alcohol swab and allow it to air-dry for 10 seconds.
4. Attach the draw needle to the syringe, pull back the plunger to draw air equal to the prescribed volume, and inject that air into the vial before drawing out the solution. This prevents vacuum formation in the vial.
5. Draw up the prescribed volume, then invert the syringe and tap to move any air bubbles upward before expelling them.
6. Swap to the injection needle. Never inject with the draw needle.

Choosing and Preparing the Injection Site

The vastus lateralis (outer middle third of the thigh) is the recommended primary site for adolescent caregiver-administered injections because it is large, easily accessible, and away from major nerves and blood vessels. The ventrogluteal site (hip) is an acceptable alternative for older adolescents who can tolerate it comfortably. [5]

Rotate the side (left vs. Right thigh) with each injection to prevent lipohypertrophy and scar tissue accumulation. Mark the schedule on a calendar. Clean the chosen spot with an alcohol swab using a circular outward motion and allow it to dry completely before inserting the needle.

Performing the Injection

1. Spread the skin taut with the non-dominant hand using the Z-track method: pull the skin 1 to 1.5 inches laterally, hold it, then insert the needle at a 90-degree angle with a smooth, quick motion.
2. After insertion, release the skin while the needle remains in place.
3. Aspirate by pulling back slightly on the plunger for 5 to 10 seconds. If blood appears, withdraw, discard the syringe, and prepare a fresh dose with new supplies. Current CDC immunization guidelines note that aspiration is not required for most IM injections into the vastus lateralis, but many clinicians still recommend it for oil-based depot injections given the viscosity and volume involved. [6]
4. Inject slowly. Testosterone enanthate is viscous; pushing the plunger too quickly causes pain and may cause tissue tracking. A pace of roughly 10 seconds per mL is appropriate.
5. Withdraw the needle smoothly at the same angle it entered. Apply gentle pressure with sterile gauze. Do not rub.
6. Dispose of the entire needle-syringe unit immediately in the sharps container.

Dosing Schedules and Titration in Adolescents

Dosing for testosterone enanthate in adolescents is individualized and substantially lower than adult replacement doses. The prescribing physician sets the schedule based on the adolescent's diagnosis, current Tanner stage, bone age, and testosterone trough levels.

Typical Dose Ranges by Indication

Constitutional delay of growth and puberty: 50 to 100 mg IM every 4 weeks for 3 to 6 months, then reassessment. The goal is a modest androgen signal to prime puberty, not full adult replacement. A 2021 Cochrane review of testosterone treatment for CDGP confirmed that low-dose short-course therapy advanced pubertal progression without causing premature epiphyseal fusion at these dose levels. [7]

Hypogonadotropic or primary hypogonadism: Starting doses of 50 mg IM every 4 weeks are common, titrated upward by 50 mg increments every 3 to 6 months toward a target of 100 to 200 mg every 2 to 4 weeks as the adolescent matures. Trough testosterone levels (drawn just before the next injection) should ideally fall in the mid-normal range for the adolescent's Tanner stage, roughly 300 to 700 ng/dL for a mid-to-late pubertal male. [3]

Never Adjust the Dose Without Physician Guidance

A caregiver must never increase the dose or shorten the injection interval based on the adolescent's mood, energy, or self-reported symptoms. Over-dosing accelerates bone age beyond chronological age, which shortens the window for linear growth and may result in reduced final adult height. A cross-sectional study of 87 adolescent males with hypogonadism found that each 6-month advance in bone age relative to chronological age was associated with a 1.8 cm reduction in predicted adult height. [8]

Monitoring: What Caregivers Track at Home

Between clinic visits, caregivers are the primary observers of the adolescent's response to therapy. Keeping a simple log helps the prescriber adjust the protocol efficiently.

Weekly Log Entries

• Injection date, site used (left or right thigh), and any local reactions (redness, swelling, nodule)
• Mood changes: notable irritability, aggression, or depression
• Sleep quality
• Any new acne, breast tenderness, or testicular pain

What the Clinic Monitors

At scheduled follow-up appointments, typically every 3 to 6 months, the physician will order:

• Serum total testosterone (trough, drawn the morning of the next scheduled injection)
• Hematocrit and hemoglobin (testosterone stimulates erythropoiesis; hematocrit above 54% warrants dose reduction or increased injection interval)
• LH and FSH (to monitor suppression of the hypothalamic-pituitary axis)
• Bone age X-ray of the non-dominant wrist (to ensure bone maturation is not advancing excessively)
• Blood pressure

The 2023 Endocrine Society guideline recommends checking hematocrit at baseline, at 3 months, and then annually once stable, with a threshold of 54% triggering dose adjustment. [3]

Side Effects Caregivers Must Recognize

Testosterone enanthate carries real risks in a still-developing endocrine system. Caregivers who know the warning signs can act before a minor issue becomes serious.

Common and Expected Effects

• Acne (often on the face, chest, or back): managed with standard topical agents; notify the prescriber if severe
• Increased body odor and oilier skin
• Mild mood fluctuations, often most noticeable in the days just after an injection as peak levels occur, then again just before the next injection as levels trough
• Growth of pubic and axillary hair, voice deepening, and penile growth (these are treatment goals, not side effects)

Side Effects That Require a Same-Day Call to the Prescriber

• Persistent erections lasting more than 4 hours (priapism): this is a urologic emergency
• Severe mood swings, aggressive behavior, or suicidal ideation
• Signs of polycythemia: headache, facial flushing, blurred vision, unusual fatigue, or shortness of breath
• Injection-site abscess: swelling with central fluctuance, warmth, and fever
• Breast tenderness with visible glandular tissue growth under the nipple (gynecomastia from aromatization to estradiol): prescriber may adjust dose or add short-course anastrozole

The Suppression Question

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis. In adolescents undergoing short-course therapy for CDGP, the expectation is that the axis recovers after the course ends and endogenous puberty resumes. This does not always happen on a predictable timeline. Caregivers should expect the clinic to verify HPG axis recovery with LH, FSH, and testosterone measurements 3 months after completing a CDGP course. [4]

Storage and Handling

Testosterone enanthate in sesame oil should be stored at controlled room temperature, 20 to 25°C (68 to 77°F), away from direct light. Do not refrigerate or freeze; the oil can congeal and make accurate dosing impossible until it re-warms. If the oil appears cloudy after storage, warm the vial briefly in the palm of the hand for 60 seconds, then re-inspect before drawing.

Multi-dose vials have a beyond-use date of 28 days after first puncture under most compounding and commercial labeling standards, though the prescriber or pharmacist may specify otherwise. Write the first-use date on the vial label with a permanent marker. [2]

Keep the vial in its original carton in a locked cabinet. Testosterone enanthate is a Schedule III controlled substance under the Controlled Substances Act; unauthorized possession or use by other household members is a federal offense. [2]

Legal and Ethical Considerations for Caregivers

Because testosterone enanthate is a Schedule III anabolic steroid, caregivers carry legal responsibility for secure storage and use only as prescribed. The DEA requires that the prescription be dispensed to the named patient only. A caregiver administering the drug to anyone other than the named adolescent patient could face criminal liability. [2]

The following decision framework captures when a caregiver should proceed with a scheduled injection versus hold and contact the prescriber:

Proceed with the injection if:

• The adolescent is afebrile and not acutely unwell
• The last injection site has fully resolved (no nodule, warmth, or swelling)
• The vial is within its beyond-use date and the solution appears normal
• No missed appointments in the current monitoring cycle

Hold the injection and contact the prescriber same day if:

• Hematocrit result from the most recent lab draw was above 54%
• The adolescent reports a persistent erection or priapism in the prior cycle
• A new injection site infection is present
• The prescriber has not reviewed labs in more than 6 months
• The adolescent has started a new medication that may interact with androgens (notably anticoagulants such as warfarin, where testosterone can potentiate the effect and raise INR)

Drug Interactions Caregivers Should Know

Testosterone enanthate has clinically meaningful interactions with several drug classes.

Anticoagulants

Testosterone potentiates the effect of warfarin and other vitamin K antagonists. The FDA-approved labeling for testosterone enanthate explicitly warns that co-administration with anticoagulants may require dose reduction of the anticoagulant and more frequent INR monitoring. [2] Any caregiver whose adolescent takes warfarin, apixaban, or rivaroxaban must inform all prescribers of the testosterone therapy.

Insulin and Antidiabetic Agents

Androgens may reduce blood glucose. In adolescents with type 1 or type 2 diabetes, testosterone therapy may increase insulin sensitivity and lower insulin requirements. A 2020 review in Diabetes Care noted that testosterone-mediated changes in insulin sensitivity can become detectable within 3 to 4 weeks of starting therapy. [9] Caregivers managing both conditions should monitor glucose more frequently for the first 8 weeks after starting testosterone enanthate.

Corticosteroids

Concurrent corticosteroid use (common in adolescents with autoimmune conditions or asthma) can increase the risk of edema and, in long-term use, may compound effects on bone turnover. The prescriber should be aware of any corticosteroid regimen before initiating testosterone enanthate.

Sharps Disposal and Community Safety

Used needles and syringes must never go in household trash or recycling bins. Most U.S. States have a mail-back program, pharmacy take-back program, or community sharps disposal bin. The FDA's safe disposal guidance recommends placing the entire needle-syringe unit (capped or uncapped) in an FDA-cleared sharps container, sealing it when three-quarters full, and disposing of it per local regulations. [10] Many pharmacies that dispense testosterone enanthate will provide a sharps container at no cost.